Journal article 857 views
Long-term safety and efficacy of linagliptin as monotherapy or in combination with other oral glucose-lowering agents in 2121 subjects with type 2 diabetes: up to 2 years exposure in 24-week phase III trials followed by a 78-week...
R Gomis,
D. R Owens,
M.-R Taskinen,
S. Del Prato,
S Patel,
A Pivovarova,
A Schlosser,
H.-J Woerle,
David Owens 
International Journal of Clinical Practice, Volume: 66, Issue: 8, Pages: 731 - 740
Swansea University Author:
David Owens
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1111/j.1742-1241.2012.02975.x
Abstract
Long-term safety and efficacy of linagliptin as monotherapy or in combination with other oral glucose-lowering agents in 2121 subjects with type 2 diabetes: up to 2 years exposure in 24-week phase III trials followed by a 78-week open-label extension
| Published in: | International Journal of Clinical Practice |
|---|---|
| ISSN: | 1368-5031 |
| Published: |
2012
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa13270 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| College: |
Faculty of Medicine, Health and Life Sciences |
|---|---|
| Issue: |
8 |
| Start Page: |
731 |
| End Page: |
740 |